355 related articles for article (PubMed ID: 7238645)
1. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
[TBL] [Abstract][Full Text] [Related]
2. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
Eernisse JG; Brand A
Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
[TBL] [Abstract][Full Text] [Related]
3. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
4. [Anti-leukocyte and anti-platelet immunization and transfusions during aplastic anemias].
Dausset J; Benbunan M
Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):132-43. PubMed ID: 781619
[No Abstract] [Full Text] [Related]
5. Sensitization by platelet transfusion.
Brand A
Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162
[TBL] [Abstract][Full Text] [Related]
6. The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation.
Tamagawa-Mineoka R; Katoh N; Ueda E; Takenaka H; Kita M; Kishimoto S
Am J Pathol; 2007 Jun; 170(6):2019-29. PubMed ID: 17525269
[TBL] [Abstract][Full Text] [Related]
7. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
8. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
9. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.
Aslam R; Speck ER; Kim M; Freedman J; Semple JW
Transfusion; 2008 Sep; 48(9):1778-86. PubMed ID: 18522705
[TBL] [Abstract][Full Text] [Related]
11. Refractory response to platelet transfusion therapy.
Eisenberg S
J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
[TBL] [Abstract][Full Text] [Related]
12. Leukopoor platelet concentrates: a direct comparison of three blood filters.
Medeiros LJ; Dzik WH
Ann Clin Lab Sci; 1985; 15(3):237-40. PubMed ID: 3994293
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
14. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
15. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
17. Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study.
Kao KJ
Blood; 1992 Dec; 80(11):2931-7. PubMed ID: 1450418
[TBL] [Abstract][Full Text] [Related]
18. Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.
Grana NH; Kao KJ
Blood; 1991 Jun; 77(11):2530-7. PubMed ID: 1828180
[TBL] [Abstract][Full Text] [Related]
19. The effect of leukocyte and platelet transfusion on the activation of intravascular coagulation by endotoxin in granulocytopenic and thrombocytopenic rabbits.
Bohn E; Müller-Berghaus G
Am J Pathol; 1976 Aug; 84(2):239-58. PubMed ID: 941978
[TBL] [Abstract][Full Text] [Related]
20. Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model.
Slichter SJ; Pellham E; Bailey SL; Christoffel T; Gettinger I; Gaur L; Latchman Y; Nelson K; Bolgiano D
Blood; 2017 Aug; 130(8):1052-1061. PubMed ID: 28705838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
